| Description | SXT1596 is a novel SS18-SSX/TLE1 interaction inhibitor. SXT1596 reduces cell viability and reactivates EGR1 expression in synovial sarcoma. |
| Synonyms | NSC-65667, SXT-1596, NSC 65667, SXT 1596, NSC65667 |
| molecular weight | 207.18 |
| Molecular formula | C10H9NO4 |
| CAS | 5438-41-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: Soluble |
| References | 1. Laporte AN, Ji JX, Ma L, Nielsen TO, Brodin BA. Identification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay. Oncotarget. 2016;7(23):34384-34394. doi:10.18632/oncotarget.8882. |